Prescribing patterns of Virechana in terms of shuddhi lakshana in various diseases: A prospective study.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- subjects undergoing classical virechana irrespective of sex, caste, religion and disease condition will be included
- Registration Number
- CTRI/2018/01/011391
- Lead Sponsor
- KLEU Shri BMK Ayurveda Mahavidyalaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
1.Subjects undergoing classical Virechana Karma
irrespective of sex, caste, religion and disease condition will be included.
Exclusion Criteria
1.Subjects not consenting for being included in the study.
2.Subjects undergoing sadyo virechana, nitya virechana are excluded
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To analyse and evaluate shuddhi lakshana in various patterns of Virechana karma prescriptionsTimepoint: 11 days
- Secondary Outcome Measures
Name Time Method ONETimepoint: NONE
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are associated with Virechana-induced shuddhi lakshana in chronic inflammatory diseases?
How does Virechana therapy compare to conventional detoxification protocols in terms of clinical efficacy and safety profiles?
Which biomarkers correlate with successful shuddhi lakshana outcomes in Virechana-treated patients with autoimmune disorders?
What adverse events are documented in CTRI/2018/01/011391 Virechana trials and how are they managed?
Are there synergistic effects when combining Virechana with modern pharmacological agents for metabolic syndrome management?